Tumour Necrotisation in Mice by Zilascorb(2H)
Author Information
Author(s): E.O. Pettersen, R.O. Larsen, J.M. Dornish, B. B0rretzen, M.E.H. Juul, T.E. Aastveit, J.M. Nesland, E.K. Rofstad, R. Oftebro
Primary Institution: Institute for Cancer Research, The Norwegian Radium Hospital
Hypothesis
Does zilascorb(2H) induce tumour necrotisation in human tumour xenografts in nude mice?
Conclusion
Zilascorb(2H) induces tumour necrotisation and inhibits tumour growth in human melanoma and ovarian carcinoma xenografts in mice.
Supporting Evidence
- Zilascorb(2H) was shown to inhibit tumour growth in both melanoma and ovarian carcinoma xenografts.
- Histological evaluations indicated a higher necrotic fraction in drug-treated tumours compared to controls.
- Protein synthesis inhibition was confirmed as the primary cellular effect of zilascorb(2H).
Takeaway
The study found that a drug called zilascorb(2H) can make tumors in mice smaller and cause them to die off, while normal cells stay healthy.
Methodology
The study involved administering zilascorb(2H) to nude mice with human tumour xenografts and measuring tumour volume and necrosis.
Limitations
The subjective nature of estimating necrotic tissue and the small sample size may limit the findings.
Participant Demographics
Female BALB/c/nu/nu/BOM mice, 9 weeks old.
Statistical Information
P-Value
0.026
Statistical Significance
p=0.026
Want to read the original?
Access the complete publication on the publisher's website